1 RESTASIS (CYCLOSPORINE) | 10 of 1440 | 1370 prescriptions Less than 1% of all prescriptions | 790 | 570 patients 39% of all patients | 390 patients 27% of all patients | |
2 XIIDRA (LIFITEGRAST) | 10 of 370 | 680 prescriptions Less than 1% of all prescriptions | 380 | 270 patients 19% of all patients | 160 patients 11% of all patients | |
3 NEOMYCIN-POLYMYXIN-DEXAMETH (NEOMYCIN/POLYMYXIN B/DEXAMETHA) | 10 of 930 | 990 prescriptions Less than 1% of all prescriptions | 610 | 860 patients 59% of all patients | 530 patients 37% of all patients | |
4 LOTEMAX (LOTEPREDNOL ETABONATE) | 70 of 350 | 250 prescriptions Less than 1% of all prescriptions | | 190 patients 13% of all patients | < 11 | |
5 TIMOLOL MALEATE | 540 of 1660 | 110 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
6 LUMIGAN (BIMATOPROST) | 300 of 1000 | 170 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
7 OLOPATADINE HCL | 110 of 410 | 200 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
8 RESTASIS MULTIDOSE (CYCLOSPORINE) | 70 of 220 | 170 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
9 KETOROLAC TROMETHAMINE | 110 of 140 | 110 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |